{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:00:52Z","timestamp":1790776852788,"version":"4.1.0"},"reference-count":108,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Pancreatic ductal adenocarcinoma (PDAC) exhibits profound resistance to current immunotherapies, a challenge largely attributed to its uniquely immunosuppressive and desmoplastic tumor microenvironment (TME). At the heart of this therapeutic recalcitrance lies the dynamic, bidirectional crosstalk between innate immune cells\u2014particularly tumor-associated macrophages (TAMs) and tumor-associated neutrophils (TANs)\u2014and stromal components, notably cancer-associated fibroblasts (CAFs). This review comprehensively delineates how the innate immunity-stroma axis establishes formidable spatial and metabolic barriers that thwart effective antitumor immunity. Spatially, dense collagen matrices, periductal fibroblast organization, and neutrophil extracellular traps (NETs) create physical checkpoints that exclude cytotoxic CD8+ T cells and natural killer (NK) cells from tumor nests. Metabolically, elevated lactate, cholesterol dysregulation, adenosine accumulation, and altered polyamine metabolism synergistically paralyze effector lymphocytes while driving immunosuppressive myeloid polarization. We highlight the key molecular networks orchestrating this pathological crosstalk, including the NF-\u03baB, IL-1\u03b2, JAK\/STAT3, and TGF-\u03b2 signaling pathways. Furthermore, we summarize emerging therapeutic strategies designed to dismantle these barriers, encompassing macrophage reprogramming, CAF modulation, and metabolic interventions. Finally, we discuss the multidimensional \u201c3D+R\u201d framework\u2014integrating de-desmoplasia, de-adenosine,\n                    <jats:italic>de-novo<\/jats:italic>\n                    antigen presentation, and rational sequencing\u2014as a conceptual roadmap for rationally designed combination therapies to overcome PDAC immunotherapy resistance.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1942345","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:32:29Z","timestamp":1790775149000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Innate immunity-stroma crosstalk in pancreatic cancer: overcoming spatial and metabolic barriers to immunotherapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Yulong","family":"Hou","sequence":"first","affiliation":[{"name":"Huzhou Central Hospital, Fifth School of Clinical Medicine of Zhejiang Chinese Medical University","place":["Huzhou, Zhejiang, China"]},{"name":"Huzhou Central Hospital, Affiliated Central Hospital of Huzhou University","place":["Huzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Tan","sequence":"additional","affiliation":[{"name":"Huzhou Central Hospital, Fifth School of Clinical Medicine of Zhejiang Chinese Medical University","place":["Huzhou, Zhejiang, China"]},{"name":"Huzhou Central Hospital, Affiliated Central Hospital of Huzhou University","place":["Huzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-334361","article-title":"Histone lactylation-driven feedback loop modulates cholesterol-linked immunosuppression in pancreatic cancer","volume":"74","author":"Yang","year":"2025","journal-title":"Gut"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-326070","article-title":"Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment","volume":"72","author":"Wang","year":"2023","journal-title":"Gut"},{"key":"B3","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.1038\/s41467-023-40727-7","article-title":"Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver metastasis","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat Commun"},{"key":"B4","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.molmed.2024.03.008","article-title":"Exploiting pancreatic cancer metabolism: challenges and opportunities","volume":"30","author":"De Santis","year":"2024","journal-title":"Trends Mol Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.ccell.2025.06.021","article-title":"Macropinocytosis maintains CAF subtype identity under metabolic stress in pancreatic cancer","volume":"43","author":"Zhang","year":"2025","journal-title":"Cancer Cell"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.70038","article-title":"Lipid metabolism reprograming by SREBP1-PCSK9 targeting sensitizes pancreatic cancer to immunochemotherapy","volume":"45","author":"Lao","year":"2025","journal-title":"Cancer Commun Lond"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-24-1712","article-title":"The immunomechanical checkpoint PYK2 governs monocyte-to-macrophage differentiation in pancreatic cancer","volume":"15","author":"Xie","year":"2025","journal-title":"Cancer Discov"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216859","article-title":"Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities","volume":"591","author":"Qin","year":"2024","journal-title":"Cancer Lett"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-19-0644","article-title":"Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15(+) Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy","volume":"10","author":"Dominguez","year":"2020","journal-title":"Cancer Discov"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116058","article-title":"Unveiling the role of KRAS in tumor immune microenvironment","volume":"171","author":"Xu","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B11","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq6221","article-title":"Neutralization of NET-associated human ARG1 enhances cancer immunotherapy","volume":"15","author":"Can\u00e8","year":"2023","journal-title":"Sci Transl Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2025.04.007","article-title":"Tumor-stromal metabolic crosstalk in pancreatic cancer","volume":"35","author":"Thakur","year":"2025","journal-title":"Trends Cell Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1172\/jci187024","article-title":"Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma","volume":"135","author":"Sun","year":"2025","journal-title":"J Clin Invest"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5226","DOI":"10.1038\/s41467-023-40895-6","article-title":"Coordinated single-cell tumor microenvironment dynamics reinforce pancreatic cancer subtype","volume":"14","author":"Oh","year":"2023","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113888","article-title":"In vivo FAP-CAR macrophages enhance chemotherapy and immunotherapy against pancreatic cancer by removing the fibrosis barrier","volume":"384","author":"Wang","year":"2025","journal-title":"J Control Release"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4123","article-title":"Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy","volume":"22","author":"Jiang","year":"2016","journal-title":"Nat Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"7827","DOI":"10.1038\/s41467-025-63146-2","article-title":"Targeting spermine metabolism to overcome immunotherapy resistance in pancreatic cancer","volume":"16","author":"Yang","year":"2025","journal-title":"Nat Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-23-0584","article-title":"Receptor-interacting protein kinase 2 is an immunotherapy target in pancreatic cancer","volume":"14","author":"Sang","year":"2024","journal-title":"Cancer Discov"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190354","article-title":"Interleukin-17-induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer","volume":"217","author":"Zhang","year":"2020","journal-title":"J Exp Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1016\/j.ccell.2023.09.014","article-title":"In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases","volume":"41","author":"Kerzel","year":"2023","journal-title":"Cancer Cell"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-20-3929","article-title":"Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-\u03baB-Mediated Production of CXCL1","volume":"81","author":"Kemp","year":"2021","journal-title":"Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.6019\/s-bsst1896","article-title":"Dissecting FAP+ Cell diversity in pancreatic cancer uncovers an interferon-response subtype of cancer-associated fibroblasts with tumor-restraining properties","volume":"85","author":"Cumming","year":"2025","journal-title":"Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1323198","article-title":"Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma","volume":"15","author":"Joseph","year":"2024","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-019-0226-9","article-title":"Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma","volume":"8","author":"Daniel","year":"2019","journal-title":"Clin Transl Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322744","article-title":"Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism","volume":"71","author":"Sun","year":"2022","journal-title":"Gut"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1717062","article-title":"Reprogramming the tumor microenvironment to overcome immunotherapy resistance in pancreatic cancer","volume":"16","author":"Hui","year":"2025","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2023.2300913","article-title":"Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance","volume":"20","author":"Zhang","year":"2024","journal-title":"Autophagy"},{"key":"B28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41392-025-02307-7","article-title":"Phosphorylated Toll-like receptor 3 nuclear translocation in cancer cell promotes metastasis and chemoresistance","volume":"10","author":"Wang","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B29","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13046-024-03178-6","article-title":"Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreatic ductal adenocarcinoma","volume":"43","author":"Luo","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325564","article-title":"Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma","volume":"72","author":"Alonso-Nocelo","year":"2023","journal-title":"Gut"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114088","article-title":"IFN\u03b1-induced BST2(+) tumor-associated macrophages facilitate immunosuppression and tumor growth in pancreatic cancer by ERK-CXCL7 signaling","volume":"43","author":"Zheng","year":"2024","journal-title":"Cell Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-22-1046","article-title":"Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreatic Cancer","volume":"13","author":"Bianchi","year":"2023","journal-title":"Cancer Discov"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-025-02134-6","article-title":"Macrophages and fibroblasts as regulators of the immune response in pancreatic cancer","volume":"26","author":"Shakiba","year":"2025","journal-title":"Nat Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.881871","article-title":"Using single cell transcriptomics to elucidate the myeloid compartment in pancreatic cancer","volume":"12","author":"Kadiyala","year":"2022","journal-title":"Front Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13122860","article-title":"Tumor-associated macrophages in pancreatic ductal adenocarcinoma: therapeutic opportunities and clinical challenges","volume":"13","author":"Poh","year":"2021","journal-title":"Cancers Basel"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.03.131","article-title":"CSF1R(+) Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype","volume":"23","author":"Candido","year":"2018","journal-title":"Cell Rep"},{"key":"B37","doi-asserted-by":"publisher","first-page":"17412","DOI":"10.1038\/s41598-024-68109-z","article-title":"CTHRC1(+) fibroblasts and SPP1(+) macrophages synergistically contribute to pro-tumorigenic tumor microenvironment in pancreatic ductal adenocarcinoma","volume":"14","author":"Li","year":"2024","journal-title":"Sci Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.7554\/elife.80721","article-title":"Arginase 1 is a key driver of immune suppression in pancreatic cancer","volume":"12","author":"Menjivar","year":"2023","journal-title":"Elife"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05351-1","article-title":"Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma","volume":"6","author":"Zhang","year":"2017","journal-title":"Cancer Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216784","article-title":"Tumor-associated macrophages drive glycolysis through the IL-8\/STAT3\/GLUT3 signaling pathway in pancreatic cancer progression","volume":"588","author":"Zhong","year":"2024","journal-title":"Cancer Lett"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.7554\/elife.73796","article-title":"Multiomic characterization of pancreatic cancer-associated macrophage polarization reveals deregulated metabolic programs driven by the GM-CSF-PI3K pathway","volume":"11","author":"Boyer","year":"2022","journal-title":"Elife"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-13-3723","article-title":"CSF1\/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models","volume":"74","author":"Zhu","year":"2014","journal-title":"Cancer Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14010194","article-title":"Macrophage and neutrophil interactions in the pancreatic tumor microenvironment drive the pathogenesis of pancreatic cancer","volume":"14","author":"Pratt","year":"2021","journal-title":"Cancers Basel"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1806714","article-title":"Tumor-associated neutrophils in pancreatic ductal adenocarcinoma: mechanisms and therapeutic targeting","volume":"17","author":"Wu","year":"2026","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"6043","DOI":"10.1038\/s41467-024-50450-6","article-title":"Necroptosis enhances \u201cdon\u2019t eat me\u201d signal and induces macrophage extracellular traps to promote pancreatic cancer liver metastasis","volume":"15","author":"Liao","year":"2024","journal-title":"Nat Commun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.133035","article-title":"Neutrophil extracellular traps in pancreatic ductal adenocarcinoma: A vicious cycle in the tumor microenvironment and targeted interventions","volume":"22","author":"Zhao","year":"2026","journal-title":"Int J Biol Sci"},{"key":"B47","doi-asserted-by":"crossref","first-page":"2601394","DOI":"10.1080\/2162402X.2025.2601394","article-title":"Neutrophil extracellular trap inhibition revitalizes PDAC immunotherapy responsiveness via reduced fibrosis and TCF1(+)CD8(+) progenitor T-cell expansion","volume":"14","author":"Niemann","year":"2025","journal-title":"Oncoimmunology"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/biom15050645","article-title":"Modulating the CXCR2 signaling axis using engineered chemokine fusion proteins to disrupt myeloid cell infiltration in pancreatic cancer","volume":"15","author":"Christopher","year":"2025","journal-title":"Biomolecules"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/jimmun\/vkaf283.643","article-title":"Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors","volume":"121","author":"Dahal","year":"2024","journal-title":"Proc Natl Acad Sci U A"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00496","article-title":"Defective localization with impaired tumor cytotoxicity contributes to the immune escape of NK cells in pancreatic cancer patients","volume":"10","author":"Lim","year":"2019","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-026-08237-4","article-title":"Multimodal transcriptomics reveal myCAF-derived collagen signaling associated with impaired NK-cell cytotoxicity and immune exclusion in pancreatic cancer","author":"Kong","year":"2026","journal-title":"J Transl Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2026.117527","article-title":"Cancer-associated fibroblast subtypes differentially modulate natural killer cells in cancer","volume":"45","author":"Rodrigues","year":"2026","journal-title":"Cell Rep"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2024.106898","article-title":"Pancreatic ductal adenocarcinoma microenvironment: Soluble factors and cancer associated fibroblasts as modulators of NK cell functions","volume":"269","author":"Carlomagno","year":"2024","journal-title":"Immunol Lett"},{"key":"B54","article-title":"Periductal fibroblast density defines lymphocyte exclusion via a CD44-dependent stromal checkpoint in pancreatic cancer","author":"Malchiodi","year":"2025","journal-title":"bioRxiv"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202415196","article-title":"Transcriptome landscape of cancer-associated fibroblasts in human PDAC","volume":"12","author":"Tao","year":"2025","journal-title":"Adv Sci Weinh"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202201460","article-title":"STAT3 in tumor fibroblasts promotes an immunosuppressive microenvironment in pancreatic cancer","volume":"5","author":"Lefler","year":"2022","journal-title":"Life Sci Alliance"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-23-0428","article-title":"Senescence defines a distinct subset of myofibroblasts that orchestrates immunosuppression in pancreatic cancer","volume":"14","author":"Belle","year":"2024","journal-title":"Cancer Discov"},{"key":"B58","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s42003-024-06087-8","article-title":"Pancreatic cancer-associated fibroblasts modulate macrophage differentiation via sialic acid-Siglec interactions","volume":"7","author":"Boelaars","year":"2024","journal-title":"Commun Biol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104965","article-title":"Dynamic crosstalk between tumor-associated macrophages and cancer-associated fibroblasts in pancreatic ductal adenocarcinoma","volume":"216","author":"Zhang","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-013175","article-title":"Oncolytic virus-induced IL-1\u03b2(+) monocyte-IL-6(+) CAF axis suppresses dendritic cell-mediated antitumor immunity in pancreatic cancer","volume":"13","author":"Li","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-19-2080","article-title":"Tumor cell-derived IL1\u03b2 Promotes desmoplasia and immune suppression in pancreatic cancer","volume":"80","author":"Das","year":"2020","journal-title":"Cancer Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-23-2352","article-title":"Multiplexed imaging mass cytometry analysis characterizes the vascular niche in pancreatic cancer","volume":"84","author":"Sussman","year":"2024","journal-title":"Cancer Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.07.025","article-title":"Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma","volume":"145","author":"Ene-Obong","year":"2013","journal-title":"Gastroenterology"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.189065","article-title":"Breaking the stromal barrier in pancreatic cancer: Advances and challenges","volume":"1879","author":"Chakkera","year":"2024","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123280","article-title":"Stromal fibrin shapes immune infiltration landscape of pancreatic ductal adenocarcinoma","volume":"320","author":"Karim","year":"2025","journal-title":"Biomaterials"},{"key":"B66","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1186\/s12967-025-06778-8","article-title":"The type I collagen paradox in PDAC progression: microenvironmental protector turned tumor accomplice","volume":"23","author":"Li","year":"2025","journal-title":"J Transl Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1650117","article-title":"Perineural invasion and the \u201ccold\u201d tumor microenvironment in pancreatic cancer: mechanisms of crosstalk and therapeutic opportunities","volume":"16","author":"Xu","year":"2025","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1101\/2021.05.21.445190","article-title":"Stromal HIF2 regulates immune suppression in the pancreatic cancer microenvironment","volume":"162","author":"Garcia Garcia","year":"2022","journal-title":"Gastroenterology"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3390\/cells15080683","article-title":"Hypoxia-induced fibroblast IL-6 promotes immunosuppressive macrophage phenotypes in pancreatic cancer","volume":"15","author":"Hannifin","year":"2026","journal-title":"Cells"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.ccell.2022.10.001","article-title":"Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy","volume":"40","author":"Li","year":"2022","journal-title":"Cancer Cell"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.643529","article-title":"Distinct stromal and immune features collectively contribute to long-term survival in pancreatic cancer","volume":"12","author":"Sadozai","year":"2021","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1170223","article-title":"Integrated transcriptomics, proteomics and metabolomics-based analysis uncover TAM2-associated glycolysis and pyruvate metabolic remodeling in pancreatic cancer","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cytogfr.2023.06.006","article-title":"Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions","author":"Bandi","year":"2023","journal-title":"Cytokine Growth Factor Rev"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-73702-z","article-title":"Metabolic characterization of the tumor microenvironment orchestrates therapeutic strategies and clinical outcomes in pancreatic cancer","author":"Tang","year":"2026","journal-title":"Nat Commun"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1172\/jci191422","article-title":"Targeting lactylation and the STAT3\/CCL2 axis to overcome immunotherapy resistance in pancreatic ductal adenocarcinoma","volume":"135","author":"Chen","year":"2025","journal-title":"J Clin Invest"},{"key":"B76","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00262-024-03898-w","article-title":"Targeting OAS3 for reversing M2d infiltration and restoring anti-tumor immunity in pancreatic cancer","volume":"74","author":"Zhang","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.180114","article-title":"Metabolic landscape of the healthy pancreas and pancreatic tumor microenvironment","volume":"9","author":"Bonilla","year":"2024","journal-title":"JCI Insight"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189443","article-title":"The CD39-CD73-adenosine axis: Master regulator of immune evasion and therapeutic target in pancreatic ductal adenocarcinoma","volume":"1880","author":"Liu","year":"2025","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1101\/2022.05.24.493238","article-title":"Defining the spatial distribution of extracellular adenosine revealed a myeloid-dependent immunosuppressive microenvironment in pancreatic ductal adenocarcinoma","volume":"11","author":"Graziano","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.218016","article-title":"Polyamines in pancreatic cancer: reshaping the immunosuppressive tumor microenvironment","volume":"633","author":"Jiang","year":"2025","journal-title":"Cancer Lett"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126350","article-title":"Targeting glycolysis in macrophages confers protection against pancreatic ductal adenocarcinoma","volume":"22","author":"Penny","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.02.035","article-title":"IRAK4 signaling drives resistance to checkpoint immunotherapy in pancreatic ductal adenocarcinoma","volume":"162","author":"Somani","year":"2022","journal-title":"Gastroenterology"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12092675","article-title":"Deciphering the role of innate immune NF-\u0138B pathway in pancreatic cancer","volume":"12","author":"Khurana","year":"2020","journal-title":"Cancers Basel"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20161707","article-title":"NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma","volume":"214","author":"Daley","year":"2017","journal-title":"J Exp Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-12-4601","article-title":"Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner","volume":"73","author":"Mace","year":"2013","journal-title":"Cancer Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2023.09.010","article-title":"CXCR4-modified CAR-T cells suppresses MDSCs recruitment via STAT3\/NF-\u03baB\/SDF-1\u03b1 axis to enhance efficacy against pancreatic cancer","volume":"31","author":"Sun","year":"2023","journal-title":"Mol Ther"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.182766","article-title":"Targeting heterogeneous tumor microenvironments in pancreatic cancer mouse models of metastasis by TGF-\u03b2 depletion","volume":"9","author":"Chen","year":"2024","journal-title":"JCI Insight"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1097\/js9.0000000000001226","article-title":"Single dual-specific anti-PD-L1\/TGF-\u03b2 antibody synergizes with chemotherapy as neoadjuvant treatment for pancreatic ductal adenocarcinoma: a preclinical experimental study","volume":"110","author":"Zhang","year":"2024","journal-title":"Int J Surg"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2024.2326694","article-title":"Transmembrane TNF-TNFR2 signaling as a critical immunoregulatory node in pancreatic cancer","volume":"13","author":"Dickey","year":"2024","journal-title":"Oncoimmunology"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1172\/jci196622","article-title":"CXCR2 blockade overcomes the NETosis-mediated resistance to MEK inhibition in pancreatic cancer models","volume":"136","author":"Herbst","year":"2026","journal-title":"J Clin Invest"},{"key":"B91","doi-asserted-by":"publisher","first-page":"10466","DOI":"10.1038\/s41598-022-14297-5","article-title":"cGAS-STING signaling encourages immune cell overcoming of fibroblast barricades in pancreatic cancer","volume":"12","author":"Kabashima","year":"2022","journal-title":"Sci Rep"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adj9366","article-title":"Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer","volume":"16","author":"Chibaya","year":"2024","journal-title":"Sci Transl Med"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-15-1346","article-title":"Macrophage PI3K\u03b3 Drives pancreatic ductal adenocarcinoma progression","volume":"6","author":"Kaneda","year":"2016","journal-title":"Cancer Discov"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1555036","article-title":"Targeting myeloid cells in pancreatic ductal adenocarcinoma: from primary tumors to liver metastasis","volume":"16","author":"Gong","year":"2025","journal-title":"Front Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"45078","DOI":"10.1038\/s41598-025-32222-4","article-title":"Blockade of CC chemokine receptor 2 suppresses pancreatic cancer progression through the interaction with macrophages in the tumor microenvironment","volume":"15","author":"Kimura","year":"2025","journal-title":"Sci Rep"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211631","article-title":"CCR2\/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma","volume":"219","author":"Wang","year":"2022","journal-title":"J Exp Med"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1713123","article-title":"CCR-CCL axes as key upstream influencers of pancreatic ductal adenocarcinoma: CCR2-CCL2, CCR5-CCL5, CCR4-CCL17\/22, CCR6-CCL20, CCR7-CCL19\/21","volume":"17","author":"Bahng","year":"2026","journal-title":"Front Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-022-00470-2","article-title":"Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer","volume":"3","author":"Cappellesso","year":"2022","journal-title":"Nat Cancer"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1619946","article-title":"Radiotherapy and immune microenvironment crosstalk in pancreatic cancer: a comprehensive review of current insights and future directions","volume":"16","author":"Xu","year":"2025","journal-title":"Front Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk1827","article-title":"Neoadjuvant radioimmunotherapy in pancreatic cancer enhances effector T cell infiltration and shortens their distances to tumor cells","volume":"10","author":"Wang","year":"2024","journal-title":"Sci Adv"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-330480","article-title":"Enhanced antitumour immunity following neoadjuvant chemoradiotherapy mediates a favourable prognosis in women with resected pancreatic cancer","volume":"73","author":"van Eijck","year":"2024","journal-title":"Gut"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell"},{"key":"B103","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"\u00d6zdemir","year":"2014","journal-title":"Cancer Cell"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.12.021","article-title":"Understanding metastasis in pancreatic cancer: a call for new clinical approaches","volume":"148","author":"Tuveson","year":"2012","journal-title":"Cell"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112681","article-title":"Integrated spatial omics of metabolic reprogramming and the tumor microenvironment in pancreatic cancer","volume":"28","author":"Wu","year":"2025","journal-title":"iScience"},{"key":"B106","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41540-023-00320-6","article-title":"An integrated study to decipher immunosuppressive cellular communication in the PDAC environment","volume":"9","author":"Av\u015far","year":"2023","journal-title":"NPJ Syst Biol Appl"},{"key":"B107","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41467-023-36296-4","article-title":"Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment","volume":"14","author":"Werba","year":"2023","journal-title":"Nat Commun"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1782960","article-title":"Overcoming multidimensional immunotherapy resistance in PDAC: from microenvironment to clinic","volume":"17","author":"Yan","year":"2026","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1942345\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:32:31Z","timestamp":1790775151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1942345\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":108,"alternative-id":["10.3389\/fimmu.2026.1942345"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1942345","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"1942345"}}